✦ LIBER ✦

Massive intrafollicular and arterial hyalinosis of the spleen following rituximab and methylprednisolone therapy in a patient with splenic marginal zone lymphoma

✍ Scribed by Schaefer, Inga-Marie; Marx, Alexander; Sauer, Christian; Hohloch, Karin; Ghadimi, B Michael; Trümper, Lorenz; Ströbel, Philipp

Book ID: 120426318
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 1021 KB
Volume: 62
Category: Article
ISSN: 0309-0167
DOI: 10.1111/his.12051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-grade transformation in splenic mar

High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis

✍ M. Dungarwalla; S. Appiah-Cubi; S. Kulkarni; R. Saso; A. Wotherspoon; N. Osuji; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

Combination therapy with rituximab and i

Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type

✍ Antonio Salar; Eva Domingo-Domenech; Cristina Estany; Miguel A. Canales; Fernand 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 3 views

Combination therapy with fludarabine and

Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma : A phase 2 trial of the Minnie Pearl Cancer Research Network

✍ John D. Hainsworth; Elizabeth R. Vazquez; David R. Spigel; Eric Raefsky; James D 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND The purpose of the current study was to evaluate the efficacy and toxicity of the combination of fludarabine and rituximab, followed by alemtuzumab, as first‐line treatment for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). ## METHO